Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.
01 9LUNDBECK PHARMS LLC
Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.
Patent Expiration Date : 2028-11-10
US Patent Number : 9629797
Drug Substance Claim :
Drug Product Claim :
Application Number : 206030
Patent Use Code : U-2004
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-11-10
Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.
Patent Expiration Date : 2028-11-10
US Patent Number : 9629797
Drug Substance Claim :
Drug Product Claim :
Application Number : 206030
Patent Use Code : U-2005
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-11-10
Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.
Patent Expiration Date : 2028-11-10
US Patent Number : 9629797
Drug Substance Claim :
Drug Product Claim :
Application Number : 206030
Patent Use Code : U-2006
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-11-10
Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.
Patent Expiration Date : 2033-02-27
US Patent Number : 9493582
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 206030
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-02-27
Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.
Patent Expiration Date : 2029-03-13
US Patent Number : 7635773
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 206030
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-03-13
Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.
Patent Expiration Date : 2029-03-13
US Patent Number : 9750822
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 206030
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-03-13
Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.
Patent Expiration Date : 2028-11-10
US Patent Number : 9770407
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 206030
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-11-10
Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.
Patent Expiration Date : 2029-03-13
US Patent Number : 8410077
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 206030
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-03-13
Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.
Patent Expiration Date : 2040-01-31
US Patent Number : 11529357
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 206030
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2040-01-31
